New drug cocktail shows promise in slowing advanced prostate cancer
Disease control
Completed
This study tested a combination of abiraterone acetate and prednisone in 131 men with advanced prostate cancer that had not yet spread on scans. The goal was to see if the drugs could lower PSA levels and delay cancer progression. Participants took daily pills alongside standard …
Phase: PHASE2 • Sponsor: Janssen Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC